Keyrus Biopharma, a contract research organization operating in Europe and part of the Keyrus Group, has standardized on Oracle Clinical and Oracle Databaseto help increase efficiency in clinical trial data collection, improve data quality and security, and support the organization’s European expansion plans.
“As a mid-size organization, we needed a reliable, but easy-to-implement clinical data management system,” said Olivier Perrot, Head of Data Management, Keyrus Biopharma.
With Oracle Clinical, Keyrus Biopharma hopes to gain greater flexibility in designing clinical trials and managing data collection, as well as increased scalability to support business expansion. The solution provides comprehensive data validation capabilities – through a library of reusable procedures based on Clinical Data Acquisition Standards Harmonization (CDash) and Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) standards.
Keyrus Biopharma worked with Pharmasol, an Oracle Gold Partner, and used Pharmasol RapidLive to accelerate the deployment cycle.
“Rapidly growing contract research organizations, like Keyrus Biopharma, require flexible and scalable health sciences applications that help them to accelerate the clinical trial process while navigating an increasingly complex regulatory environment,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.